
Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases
Keywords: BC; breast cancer; BM; bone metastases; BPs; bisphosphonates; CSD; cold shock domain; CT; computed tomography; CTCs; circulating tumor cells; CV; coefficient of variation; EMT; epithelial-to-mesenchymal transition; HCC; hepatocellular carcinoma; IL-6; int